**5. Conclusions**

Participants used multiple medical cannabis products to treat a number of medical conditions in conjunction with multiple prescription, over-the-counter, complementary, and alternative products. There is a high rate of variability from time point to time point as to what products people are using, so it is best to continually reassess patient use of medical cannabis products.

**Author Contributions:** Conceptualization, E.R.H., E.L.K. and B.K.W.; methodology, E.R.H., E.L.K. and B.K.W.; software, E.L.K. and A.H.; validation, E.L.K. and A.H.; formal analysis, A.H. and E.L.K.; investigation, A.H. and K.M.; resources, B.K.W. and E.L.K.; data curation, E.R.H., A.H., K.M., J.M.L. and B.K.W.; writing—original draft preparation, E.R.H.; writing—review and editing, E.R.H., A.H., E.L.K., K.M., J.M.L. and B.K.W.; visualization, E.R.H., A.H. and E.L.K.; supervision, B.K.W.; project administration, E.L.K., A.H., K.M. and B.K.W.; funding acquisition. B.K.W. All authors have read and agreed to the published version of the manuscript.

**Funding:** MLH Explorations, LLC.

**Institutional Review Board Statement:** The study was conducted according to the guidelines of the Declaration of Helsinki and approved by the Institutional Review Board of Thomas Jefferson University (IRB# 17C.478 approved 12/18/19).

**Informed Consent Statement:** Informed consent was obtained from all subjects involved in the study.

**Conflicts of Interest:** The authors declare no conflict of interest.
